RxDoctor Payments Data

Sheila Branson

Nurse Practitioner · Williamsburg, VANPI 1760420400

Payments from drug & device makers

$2,486in general payments, 2019–2025

Across 122 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$671
  • AbbVie$352
  • Amgen$256
  • Pfizer$173
  • AstraZeneca$167
  • Lilly USA, LLC$154
  • plus $714 from 21 others

What the payments were for

  • Food & beverage$2,486100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,486 in reported general payments places this provider in the 90th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide96$129,351
EliquisApixaban105$107,664
JardianceEmpagliflozin50$46,637
FarxigaDapagliflozin Propanediol33$36,562
MounjaroTirzepatide24$31,932
XareltoRivaroxaban22$23,799
Tresiba Flextouch U-200Insulin Degludec19$14,868
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$14,444
MyrbetriqMirabegron20$8,952
LinzessLinaclotide12$7,550
SymbicortBudesonide/Formoterol Fumarate14$4,501
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$4,360
Humalog Kwikpen U-100Insulin Lispro16$2,918
Atorvastatin Calcium376$2,873
Metoprolol Succinate202$2,693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$671$129,35196 claims
PfizerEliquis$173$107,664105 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$167$55,50766 claims
Lilly USA, LLCMounjaro$154$31,93224 claims
AbbVieLinzess$352$7,55012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Williamsburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →